
 
													 
									 
															 
															Year
 
															DEALS // DEV.
 
															Country
 
															 
															Therapeutic Area
 
															Study Phase
 
															Deal Type
 
															Product Type
 
															Dosage Form
 
															Lead Product
 
															Target

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Indocyanine Green
Therapeutic Area : Endocrinology
Study Phase : Phase IV
Recipient : University of Alabama at Birmingham
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Indocyanine Green is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Parathyroid Diseases.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 13, 2023
Lead Product(s) : Indocyanine Green
Therapeutic Area : Endocrinology
Highest Development Status : Phase IV
Recipient : University of Alabama at Birmingham
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Indocyanine Green
Therapeutic Area : Gastroenterology
Study Phase : Phase IV
Recipient : University Health Network, Toronto
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Indocyanine Green is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Stomach Ulcer.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 21, 2023
Lead Product(s) : Indocyanine Green
Therapeutic Area : Gastroenterology
Highest Development Status : Phase IV
Recipient : University Health Network, Toronto
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Indocyanine Green
Therapeutic Area : Oncology
Study Phase : Phase II
Sponsor : Kurt Weiss
Deal Size : Inapplicable
Deal Type : Inapplicable
Fluorescent Intra-operative Tumor Margin Examination
Details : Indocyanine Green is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Sarcoma.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 22, 2021
Lead Product(s) : Indocyanine Green
Therapeutic Area : Oncology
Highest Development Status : Phase II
Sponsor : Kurt Weiss
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Paracetamol
Therapeutic Area : Neurology
Study Phase : Phase II
Recipient : Virginia Commonwealth University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Acetaminophen is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Postoperative Cognitive Complications.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 13, 2019
Lead Product(s) : Paracetamol
Therapeutic Area : Neurology
Highest Development Status : Phase II
Recipient : Virginia Commonwealth University
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Chlorhexidine Gluconate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Angela Bianco
Deal Size : Inapplicable
Deal Type : Inapplicable
Preoperative Application of Chlorhexidine to Reduce Infection With Cesarean Section After Labor
Details : Chlorhexidine Gluconate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Surgical Wound Infection.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 06, 2018
Lead Product(s) : Chlorhexidine Gluconate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Angela Bianco
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase IV
Recipient : University of Texas Health Science Center at Houston
Deal Size : Inapplicable
Deal Type : Inapplicable
SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke
Details : This drug candidate is currently being evaluated in phase IV clinical studies for the treatment of Stroke.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 28, 2017
Lead Product(s) : Undisclosed
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase IV
Recipient : University of Texas Health Science Center at Houston
Deal Size : Inapplicable
Deal Type : Inapplicable

Details : IC2000 is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Breast Neoplasms.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
June 27, 2017

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Chlorhexidine Gluconate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Recipient : Vanderbilt University
Deal Size : Inapplicable
Deal Type : Inapplicable
2% Chlorhexidine Gluconate Skin Cloths to Prevent SSI in Spine Surgery Patients
Details : Chlorhexidine Gluconate is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Surgical Wound Infection.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 07, 2015
Lead Product(s) : Chlorhexidine Gluconate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Recipient : Vanderbilt University
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Indocyanine Green
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Phase I
Recipient : Ohio State University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Indocyanine Green is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Cholecystitis, Acute.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 25, 2014
Lead Product(s) : Indocyanine Green
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Phase I
Recipient : Ohio State University
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Bone Morphogenetic Protein-7
Therapeutic Area : Musculoskeletal
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Bone Morphogenetic Protein-7 is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Osteoarthritis, Knee.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
May 31, 2010
Lead Product(s) : Bone Morphogenetic Protein-7
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

 Reset All
Reset All